Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Nigel Hurst"'
Publikováno v:
Osteoporosis International. 16:483-489
Objectives: There have been no studies of generic health-related quality of life (HR-QOL) measured prospectively, in patients referred for bone mass measurement. The aim of this study was to examine the relationship between HR-QOL, measured before DX
Publikováno v:
Osteoporosis International. 14:326-333
The objective of the study was to assess the impact of direct access DXA scanning (DADS) upon GPs' management decisions in patients considered to be at risk of osteoporosis. It was designed as a randomized, prospective, parallel group trial, set with
Autor:
Roy L. Beddoes, David Nigel Hurst, Michael Richard Attwood, Peter Quayle, M. L. Lewis, Y. Zhao
Publikováno v:
Tetrahedron Letters. 36:2641-2644
Steric rather than electrostatic interactions have been shown to be the controlling factor in the stereochemistry of enolate generation of β-trialkylstannylpropionates.
Autor:
Michael Richard Attwood, Sanjit Johal, David Nigel Hurst, Peter Quayle, M. L. Lewis, Roy L. Beddoes
Publikováno v:
Tetrahedron Letters. 36:471-474
A stereospecific 1,3-elimination reaction of γ-hydroxy stannanes has been employed in the synthesis of 2-oxabicyclo[3.1.0]hexanes.
Publikováno v:
ChemInform. 22
Autor:
Y. Zhao, Michael Richard Attwood, Peter Quayle, Roy L. Beddoes, M. L. Lewis, David Nigel Hurst
Publikováno v:
ChemInform. 26
Steric rather than electrostatic interactions have been shown to be the controlling factor in the stereochemistry of enolate generation of β-trialkylstannylpropionates.
Autor:
David Nigel Hurst, Rachel M. Dunsdon, Michael Richard Attwood, Kay Paul Brittain, P. Jones, Barbara S. Brown
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 2:229-234
The preparation of several homochiral benzopyranyl potassium channel openers is described. A subtle stereochemical effect of the 3-hydroxyl group on the biological activities of the enantiomers was observed.
Autor:
David Spalding, Adrian Hall, Gerard Martin Paul Giblin, Nicholas Maughan Clayton, Rino A. Bit, Tiziana Scoccitti, Iain P. Chessell, Anita Chowdhury, Riccardo Novelli, David Nigel Hurst, Alan Naylor, Alex W. Wilson, Helene M. Chaignot, Sac P. Tang, Susan H. Brown, Rich Wilson, Beverley Hammond, Anton D. Michel, Tanya Coleman
Publikováno v:
Bioorganicmedicinal chemistry letters. 17(2)
The discovery of a series of selective EP1 receptor antagonists based on a 1,2-diarylcyclopentene template is described. After defining the structural requirements for EP1 potency and selectivity, heterocyclic rings were incorporated to reduce log D
Autor:
Michael J. Broadhurst, Trevor C.I. Wilkinson, Stephen D. Pickett, P. Jones, Murray McKinnell, James M. Bennett, Bradley S Sherborne, Neera Borkakoti, David Nigel Hurst, Ian Reginald Kilford
Publikováno v:
Bioorganicmedicinal chemistry letters. 13(10)
Novel, low molecular weight inhibitors of IMPDH have been discovered through the application of a validated virtual screening protocol. A series of 21 IMPDH inhibitors were used to validate the docking procedure. Application of this procedure to the
Autor:
Rosemary A. Melarange, David Nigel Hurst, Peter James Machin, Celia Shivdasani, Rachel M. Bradshaw, David T. Burden, Allison D. Fryer, Leslie C. Blaber
Publikováno v:
Journal of medicinal chemistry. 26(11)
A series of 4-substituted phenoxypropanolamines was prepared and examined for beta-adrenoceptor activity. Some of the compounds, especially the [4-[2-[[2-(4-fluorophenyl)ethyl] oxy]ethoxy]phenoxy]propanolamines (14, 15, and 24), showed potent beta 1-